[go: up one dir, main page]
More Web Proxy on the site http://driver.im/
You seem to have javascript disabled. Please note that many of the page functionalities won't work as expected without javascript enabled.
 
 
Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

Article Types

Countries / Regions

Search Results (67)

Search Parameters:
Keywords = mediastinal mass

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
15 pages, 5311 KiB  
Review
Local Anesthetic Infiltration, Awake Veno-Venous Extracorporeal Membrane Oxygenation, and Airway Management for Resection of a Giant Mediastinal Cyst: A Narrative Review and Case Report
by Felix Berger, Lennart Peters, Sebastian Reindl, Felix Girrbach, Philipp Simon and Christian Dumps
J. Clin. Med. 2025, 14(1), 165; https://doi.org/10.3390/jcm14010165 - 30 Dec 2024
Viewed by 295
Abstract
Background: Mediastinal mass syndrome represents a major threat to respiratory and cardiovascular integrity, with difficult evidence-based risk stratification for interdisciplinary management. Methods: We conducted a narrative review concerning risk stratification and difficult airway management of patients presenting with a large mediastinal mass. This [...] Read more.
Background: Mediastinal mass syndrome represents a major threat to respiratory and cardiovascular integrity, with difficult evidence-based risk stratification for interdisciplinary management. Methods: We conducted a narrative review concerning risk stratification and difficult airway management of patients presenting with a large mediastinal mass. This is supplemented by a case report illustrating our individual approach for a patient presenting with a subtotal tracheal stenosis due to a large cyst of the thyroid gland. Results: We identified numerous risk stratification grading systems and only a few case reports of regional anesthesia techniques for extracorporeal membrane oxygenation patients. Clinical Case: After consultation with his general physician because of exertional dyspnea and stridor, a 78-year-old patient with no history of heart failure was advised to present to a cardiology department under the suspicion of decompensated heart failure. Computed tomography imaging showed a large mediastinal mass that most likely originated from the left thyroid lobe, with subtotal obstruction of the trachea. Prior medical history included the implantation of a dual-chamber pacemaker because of a complete heart block in 2022, non-insulin-dependent diabetes mellitus type II, preterminal chronic renal failure with normal diuresis, arterial hypertension, and low-grade aortic insufficiency. After referral to our hospital, an interdisciplinary consultation including experienced cardiac anesthesiologists, thoracic surgeons, general surgeons, and cardiac surgeons decided on completing the resection via median sternotomy after awake cannulation for veno-venous extracorporeal membrane oxygenation via the right internal jugular and the femoral vein under regional anesthesia. An intermediate cervical plexus block and a suprainguinal fascia iliaca compartment block were performed, followed by anesthesia induction with bronchoscopy-guided placement of the endotracheal tube over the stenosed part of the trachea. The resection was performed with minimal blood loss. After the resection, an exit blockade of the dual chamber pacemaker prompted emergency surgical revision. The veno-venous extracorporeal membrane oxygenation was explanted after the operation in the operating room. The postoperative course was uneventful, and the patient was released home in stable condition. Conclusions: Awake veno-venous extracorporeal membrane oxygenation placed under local anesthetic infiltration with regional anesthesia techniques is a feasible individualized approach for patients with high risk of airway collapse, especially if the mediastinal mass critically alters tracheal anatomy. Compressible cysts may represent a subgroup with easy passage of an endotracheal tube. Interdisciplinary collaboration during the planning stage is essential for maximum patient safety. Prospective data regarding risk stratification for veno-venous extracorporeal membrane oxygenation cannulation and effectiveness of regional anesthesia is needed. Full article
(This article belongs to the Special Issue Clinical Advances in Cardiothoracic Anesthesia)
Show Figures

Figure 1

Figure 1
<p>Initial CT imaging of the (<b>a</b>) coronal plane and (<b>b</b>) axial plane: compression of the trachea (arrow: minimum diameter of 3 mm/subtotal collapse) due to the cyst (*), and a shift in anterior mediastinal structures to the right side of the patient.</p>
Full article ">Figure 2
<p>Preoperative chest X-ray with prominent tracheal deviation.</p>
Full article ">
19 pages, 2762 KiB  
Review
The Role of Advanced Cardiac Imaging in Monitoring Cardiovascular Complications in Patients with Extracardiac Tumors: A Descriptive Review
by Annamaria Tavernese, Valeria Cammalleri, Rocco Mollace, Giorgio Antonelli, Mariagrazia Piscione, Nino Cocco, Myriam Carpenito, Carmelo Dominici, Massimo Federici and Gian Paolo Ussia
J. Cardiovasc. Dev. Dis. 2025, 12(1), 9; https://doi.org/10.3390/jcdd12010009 - 29 Dec 2024
Viewed by 454
Abstract
Cardiac involvement in cancer is increasingly important in the diagnosis and follow-up of patients. A thorough cardiovascular evaluation using multimodal imaging is crucial to assess any direct cardiac involvement from oncological disease progression and to determine the cardiovascular risk of patients undergoing oncological [...] Read more.
Cardiac involvement in cancer is increasingly important in the diagnosis and follow-up of patients. A thorough cardiovascular evaluation using multimodal imaging is crucial to assess any direct cardiac involvement from oncological disease progression and to determine the cardiovascular risk of patients undergoing oncological therapies. Early detection of cardiac dysfunction, particularly due to cardiotoxicity from chemotherapy or radiotherapy, is essential to establish the disease’s overall prognostic impact. Comprehensive cardiovascular imaging should be integral to the clinical management of cancer patients. Echocardiography remains highly effective for assessing cardiac function, including systolic performance and ventricular filling pressures, with speckle-tracking echocardiography offering early insights into chemotoxicity-related myocardial damage. Cardiac computed tomography (CT) provides precise anatomical detail, especially for cardiac involvement due to metastasis or adjacent mediastinal or lung tumors. Coronary assessment is also important for initial risk stratification and monitoring potential coronary artery disease progression after radiotherapy or chemotherapeutic treatment. Finally, cardiac magnetic resonance (CMR) is the gold standard for myocardial tissue characterization, aiding in the differential diagnosis of cardiac masses. CMR’s mapping techniques allow for early detection of myocardial inflammation caused by cardiotoxicity. This review explores the applicability of echocardiography, cardiac CT, and CMR in cancer patients with extracardiac tumors. Full article
Show Figures

Figure 1

Figure 1
<p>Global longitudinal strain (GLS) analysis and three-dimensional (3D) left ventricle ejection fraction (LVEF) of a breast cancer patient undergoing trastuzumab therapy. Significant reduction in 3D LVEF and GLS after 6 months of treatment (Panel <b>A</b> + Panel <b>B</b>). Improvement of 3D LVEF and GLS after 4 months post-therapy cessation and initiation of cardioprotective treatment (Panel <b>C</b> + Panel <b>D</b>).</p>
Full article ">Figure 2
<p>A 47-year-old patient undergoing anthracycline therapy for the treatment of breast cancer underwent a cardiac MRI following the detection of a mild reduction in left ventricular ejection fraction on echocardiography: post-contrast sequences do not reveal areas of myocardial late gadolinium enhancement (Panel <b>A</b> and Panel <b>B</b>). Native T1 mapping, measured by placing a ROI in the mid interventricular septum, is slightly increased (Panel <b>C</b>). The ECV, obtained through post-contrast T1 mapping sequences, is diffusely elevated (Panel <b>D</b>). These findings are indicative of diffuse interstitial inflammation due to chemotherapy-induced toxicity, supporting the prognostic role of T1 mapping independently.</p>
Full article ">Figure 3
<p>A 62-year-old patient with a history of prior exposure to radiotherapy for the treatment of Hodgkin’s lymphoma underwent a computed tomography scan for atypical angina. High pitch spiral (FLASH) coronary artery calcium (CAC) imaging shows diffuse calcifications of the coronary arteries; a CT attenuation threshold of 130 Hounsfield units (HU) is used for the detection of calcium (Panel <b>A</b>); a CAC score of 1391 Ag was obtained using an equivalent scoring method to the Agatston score (Panel <b>B</b>); The subsequent coronary CT angiography reveals diffuse coronary atheromatous with significant stenosis of the circumflex artery (Panel <b>C</b> and Panel <b>D</b>).</p>
Full article ">
3 pages, 456 KiB  
Interesting Images
IgG4-Related Lymphadenopathy Mimicking Mediastinal Lymph Node Metastasis of Lung Cancer on 18F-FDG PET/CT
by Ting-Chun Tseng, Hung-Pin Chan, Daniel Hueng-Yuan Shen and Chang-Chung Lin
Diagnostics 2025, 15(1), 41; https://doi.org/10.3390/diagnostics15010041 - 27 Dec 2024
Viewed by 314
Abstract
We report a case of a 73-year-old man with minimally invasive lung adenocarcinoma, post-resection, evaluated with 18F-FDG PET/CT for suspected disease progression. Imaging showed increased FDG uptake in the right lower lung mass and systemic lymphadenopathy (mediastinal, supraclavicular, axillary, paraaortic, and iliac [...] Read more.
We report a case of a 73-year-old man with minimally invasive lung adenocarcinoma, post-resection, evaluated with 18F-FDG PET/CT for suspected disease progression. Imaging showed increased FDG uptake in the right lower lung mass and systemic lymphadenopathy (mediastinal, supraclavicular, axillary, paraaortic, and iliac regions). The appearance of a stable lymph node and a clinical history of IgG4 lymphadenopathy suggested an inflammatory process, although malignancy in the lung mass and mediastinal nodes could not be excluded. Lobectomy confirmed the presence of lung adenocarcinoma, while radical lymph node dissection identified IgG4-related lymphadenopathy without metastasis. This case underscores the need for considering differential diagnosis of PET-positive lymphadenopathy, especially in patients with comorbid conditions that mimic or coexist with malignancy. Full article
(This article belongs to the Collection Interesting Images)
Show Figures

Figure 1

Figure 1
<p>A 73-year-old male with stage IA minimally invasive lung adenocarcinoma, a status confirmed post-surgical wedge resection at age 66, underwent <sup>18</sup>F-FDG PET/CT due to suspected disease progression on routine 3-month chest CT follow-ups. The maximum intensity projection coronal PET (<b>A</b>) revealed low-grade FDG activity in the right lower lung (RLL) tumor mass (SUVmax 4.6; (<b>B</b>), white arrowhead). Multiple FDG-avid lymphadenopathies were identified, including the mediastinal, bilateral supraclavicular (largest node measuring 12 mm; (<b>B</b>), yellow arrows), bilateral axillary (largest node 18 mm on the left; (<b>B</b>), yellow arrowhead), paraaortic (12 mm; (<b>B</b>), white arrows), and iliac nodes, with the left axillary lymph node showing the highest SUVmax of 7.7. The absence of systemic organ involvement made metastatic disease less probable. Serial chest CT scans, including one performed at age 67 (<b>C</b>), consistently showed no significant changes in the size or appearance of the bilateral supraclavicular ((<b>C</b>); yellow arrows) and axillary lymph nodes ((<b>C</b>); yellow arrowhead), reducing the likelihood of malignant spread. The symmetrical and systemic distribution of the lymphadenopathy suggested benign etiologies, such as inflammatory or lymphoproliferative disorders. Differentiation between lymphoma and inflammatory lymphadenopathy can be guided by two PET/CT observations and three clinical indicators: a high SUVmax liver ratio, elevated SUVmax in retroperitoneal lymph nodes, older age, a reduced erythrocyte sedimentation rate, and a low platelet count [<a href="#B1-diagnostics-15-00041" class="html-bibr">1</a>]. Given the low probability of lymphoma and lack of clinical correlation, the patient’s FDG-avid lymphadenopathies were deemed inflammatory. Notably, at the age of 59, the patient was diagnosed with IgG4 lymphadenopathy, confirmed by a left axillary lymph node biopsy revealing IgG4-positive transformed germinal centers and elevated serum IgG4 levels. This history supports IgG4-related lymphadenopathy as a probable diagnosis. Although rare, both IgG4-related inflammatory pseudotumors mimicking primary lung cancer [<a href="#B2-diagnostics-15-00041" class="html-bibr">2</a>,<a href="#B3-diagnostics-15-00041" class="html-bibr">3</a>] and lung cancer concomitant with IgG4-related disease [<a href="#B4-diagnostics-15-00041" class="html-bibr">4</a>] have been reported. For this patient, the RLL tumor mass and mediastinal lymphadenopathy required further evaluation to exclude cancerous processes. Differentiation using PET/CT can be challenging, as these pseudotumors often exhibit SUVmax values ranging from 3.4 to 10, with associated mediastinal and hilar lymphadenopathy showing SUVmax values between 2.8 and 3.9, overlapping with early-stage NSCLC (median SUVmax 3.2, range 0.7–13.3) [<a href="#B5-diagnostics-15-00041" class="html-bibr">5</a>]. Nevertheless, PET/CT remains valuable for identifying multi-organ involvement in IgG4-related disease prior to treatment [<a href="#B6-diagnostics-15-00041" class="html-bibr">6</a>] and monitoring the response to prednisone-based therapy [<a href="#B7-diagnostics-15-00041" class="html-bibr">7</a>], potentially reducing the need for biopsies. The patient subsequently underwent lobectomy, which revealed an acinar predominant adenocarcinoma, pT2aN0M0, stage IB. Radical lymph node dissection confirmed IgG4-related lymphadenopathy without metastasis. Histopathology demonstrated Bcl2 negativity in germinal centers, IgD positivity in mantle cells and the marginal zone, and an IgG4+/IgG+ plasma cell ratio of 45%, consistent with IgG4-related lymphadenopathy. This case underscores the importance of integrating clinical history, imaging comparisons, and alternative diagnoses, particularly when malignancy coexists with mimicking conditions [<a href="#B8-diagnostics-15-00041" class="html-bibr">8</a>]. Correlating PET/CT findings with clinical context is essential for accurate diagnosis and management.</p>
Full article ">
9 pages, 1402 KiB  
Article
Changes in the Epidemiology of Thoracic and Cardiovascular Diseases in Korea During the COVID-19 Pandemic: A Nationwide Analysis
by Jung Ho Park, Hong Kyu Lee, Hyoung Soo Kim, Kunil Kim, Yong Joon Ra and Jeong Wook Kang
J. Clin. Med. 2024, 13(23), 7059; https://doi.org/10.3390/jcm13237059 - 22 Nov 2024
Viewed by 562
Abstract
Background/Objectives: There is limited evidence regarding the impact of the coronavirus disease 2019 (COVID-19) pandemic on the epidemiology of thoracic and cardiovascular diseases. This study aimed to investigate changes in medical visits for these conditions during the COVID-19 pandemic. Methods: We analyzed the [...] Read more.
Background/Objectives: There is limited evidence regarding the impact of the coronavirus disease 2019 (COVID-19) pandemic on the epidemiology of thoracic and cardiovascular diseases. This study aimed to investigate changes in medical visits for these conditions during the COVID-19 pandemic. Methods: We analyzed the entire Korean population (~50 million) for monthly medical visits for 15 common thoracic and cardiovascular conditions, including pneumothorax, large bullae, lung cancer, esophageal cancer, thymoma, empyema, mediastinitis, esophageal rupture, multiple rib fractures, hemothorax, rib mass, varicose vein, pectus excavatum, aortic dissection, aortic aneurysm, and valve disease from January 2019 to December 2021. Data were obtained from the Korean National Health Insurance Service using the International Classification of Disease (ICD)-10 codes. Variations in the mean monthly medical visits of 15 frequent thoracic and cardiovascular diseases before and during the COVID-19 pandemic were compared using the Mann–Whitney U test, while changes in variance were assessed using Levene’s test. Results: The mean monthly number of medical visits for pneumothorax and large bullae significantly decreased during the COVID-19 pandemic compared to before the pandemic (by 10.1% and 12.8%; both p < 0.001). On the contrary, there was a significant increase in the mean monthly counts of medical visits for lung cancer, esophageal cancer, thymoma, and valve disease diagnosis (by 6.6%, 5.3%, 8.8%, and 5.0%, respectively; all p < 0.05). Conclusions: In Korea, the number of diagnosed cases of pneumothorax significantly decreased during the COVID-19 pandemic compared to before COVID-19, while diagnoses of thoracic cancers and valve disease increased. Full article
(This article belongs to the Special Issue Clinical Consequences of COVID-19: 2nd Edition)
Show Figures

Figure 1

Figure 1
<p>Monthly incidence of thoracic diseases during 2019, 2020, and 2021.</p>
Full article ">
15 pages, 4179 KiB  
Case Report
Mediastinal Teratoma with Nephroblastomatous Elements: Case Report, Literature Review, and Comparison with Maturing Fetal Glomerulogenic Zone/Definitive Zone Ratio and Nephrogenic Rests
by Bader Alfawaz, Khaldoun Koujok, Gilgamesh Eamer and Consolato M. Sergi
Int. J. Mol. Sci. 2024, 25(22), 12427; https://doi.org/10.3390/ijms252212427 - 19 Nov 2024
Viewed by 633
Abstract
Extrarenal teratoid Wilms’ tumor (TWT) is a variant of Wilms’ tumor with fewer than 30 cases reported in the literature. It comprises more than 50% heterologous tissue and presents a significant diagnostic challenge due to its complex histology. We report an unusual case [...] Read more.
Extrarenal teratoid Wilms’ tumor (TWT) is a variant of Wilms’ tumor with fewer than 30 cases reported in the literature. It comprises more than 50% heterologous tissue and presents a significant diagnostic challenge due to its complex histology. We report an unusual case of mediastinal teratoma with nephroblastomatous elements in an 8-year-old female. The patient presented with respiratory distress, fever, weight loss, and a large anterior mediastinal mass. Imaging revealed a heterogeneous tumor containing fat, fluid, and calcification, suggestive of a teratoma. Surgical resection confirmed a mature cystic teratoma with foci of nephroblastoma. Pathological analysis demonstrated a mixture of ectodermal, mesodermal, and endodermal tissues alongside nephroblastomatous components. Immunohistochemistry was positive for Wilms Tumor 1 and other relevant markers, confirming the diagnosis. The patient had an uneventful postoperative course and was discharged after three days. This case adds to the growing body of research on extrarenal TWT, particularly its occurrence in the mediastinum, a rare site for such tumors. A literature review highlighted that extrarenal TWT often affects children, typically presenting in the retroperitoneum or sacrococcygeal regions, with varying recurrence rates and long-term outcomes. This case underscores the importance of histopathological and immunohistochemical analysis in diagnosing TWT and differentiating it from other mediastinal tumors to ensure appropriate treatment planning, emphasizing the need for long-term follow-up due to the potential for recurrence or metastasis. This paper also provides an in-depth look at nephron development and nephrogenic rests, highlighting the structural and functional aspects of nephrogenesis and the factors that disrupt it in fetal kidneys. Full article
Show Figures

Figure 1

Figure 1
<p>Imaging. (<b>a</b>) This PA view of the chest demonstrates a large mass on the right side of the chest (arrows). (<b>b</b>) A lateral view shows that the mass in the anterior mediastinum overlaps with the heart shadow. Axial (<b>c</b>) and coronal (<b>d</b>) contrast-enhanced CT images demonstrate an anterior mediastinal tumor (large arrows) causing mass effects in the heart and great vessels. It contains fat (small arrows), fluid, and calcification (curved arrow). The location and the presence of fat, fluid, and calcification are characteristic of a teratoma.</p>
Full article ">Figure 2
<p><b>The histology and immunohistochemistry of the mediastinal tumor.</b> This figure includes four microphotographs with included scale bars, i.e., (<b>a</b>) hematoxylin and eosin staining (200× magnification, scale bar 50 μm); (<b>b</b>) WT1 expression (100× magnification, scale bar 100 μm); (<b>c</b>) PAX8 expression (100× magnification, scale bar 100 μm); and (<b>d</b>) expression of CD56, which is a sensitive neuroendocrine marker (40× magnification, scale bar 100 μm). <span class="html-italic">PAX8</span> is a gene that encodes a transcription factor involved in the development of the thyroid, renal, and Müllerian systems.</p>
Full article ">Figure 3
<p><b>The glomerulogenic zone during ontogenesis.</b> The glomerulogenic zone varies during ontogenesis with a decrease in thickness as the pregnancy reaches full term. The ratio of the glomerulogenic zone (GZ) to the definitive zone (DZ) is particularly critical because it mirrors the maturation of the renal parenchyma. GZ/DZ at 17 + 2 weeks of gestation (<b>a</b>), 20 + 1 weeks of gestation (<b>b</b>), 22 + 6 weeks of gestation (<b>c</b>), and 39 + 6 weeks of gestation (<b>d</b>) (hematoxylin and eosin staining). Scale bars (100 μm) are embedded in the microphotographs a, c, and d. The microphotograph b was taken at the same magnification as c. Thus, the scale bar used for the microphotograph c can be used for the microphotograph b. All microphotographs were taken during clinical autopsies performed after spontaneous stillbirths without evidence of maturation delay, and no congenital anomalies were identified during the autopsies. In all cases, consent for autopsy was granted without restrictions, and there was permission to use microphotographs for academic and educational purposes.</p>
Full article ">Figure 4
<p>Schematic reproduction of a metanephric blastema and its evolution. A metanephric blastema steadily induces the ureteric bud to branch. The bud counteracts, tightly condensing. Sequentially, the blastema initiates renal differentiation. Potential sequelae are also displayed (see the text for details).</p>
Full article ">
16 pages, 8753 KiB  
Case Report
Ectopic Mediastinal Thyroid: A Crossroad Between a Multi-Layered Endocrine Perspective and a Contemporary Approach in Thoracic Surgery
by Claudiu Nistor, Mihai-Lucian Ciobica, Oana-Claudia Sima, Anca-Pati Cucu, Florina Vasilescu, Lucian-George Eftimie, Dana Terzea, Mihai Costachescu, Adrian Ciuche and Mara Carsote
Life 2024, 14(11), 1374; https://doi.org/10.3390/life14111374 - 25 Oct 2024
Viewed by 764
Abstract
An ectopic thyroid (ET) involves numerous scenarios of detection and outcomes, while its current management is not standardised. A mediastinal ET (MET) represents a low index of suspicion. In this paper, we introduce a 47-year-old female who was accidentally identified with an MET, [...] Read more.
An ectopic thyroid (ET) involves numerous scenarios of detection and outcomes, while its current management is not standardised. A mediastinal ET (MET) represents a low index of suspicion. In this paper, we introduce a 47-year-old female who was accidentally identified with an MET, and a modern surgical approach was provided. An anterior mediastinal mass of 3.2 cm was found at CT upon a prior COVID-19 infection. Previous to the infection, she experienced non-specific complaints for a few months (intermittent night sweats, facial erythema, chest pressure, and dyspnoea). Also, CT identified a thymus-like mass and a left adrenal incidentaloma of 3 cm. The endocrine panel was normal, and the subject declined further investigations. She was re-admitted 12 months later: the MET had increased +1 cm (+45% volume) and was confirmed at a 99mTc pertechnetate scintigraphy. Noting the symptoms, mediastinal anatomy, and size change, the MET was removed via a minimally invasive trans-cervical approach (eutopic gland preservation) with the help of a Cooper thymectomy retractor (which also allowed for a synchronous thymus mass resection). No post-operatory complications were registered, the thyroid function remained normal, and the mentioned symptoms were remitted. A histological exam confirmed a benign MET and thymus hyperplasia, respectively. To conclude, this case pinpoints important aspects, such as the clinical picture became clear only upon thoracic surgery due to the complete remission of the complaints that initially seemed widely non-specific. The incidental MET finding was associated with a second (adrenal) incidentaloma, a scenario that might not be so rare, following multiple imaging scans amid the COVID-19 era (no common pathogenic traits have been identified so far). The co-presence of a thymus mass represented one more argument for surgery. Minimally invasive cervicotomy associated with eutopic gland conservation and the use of a Cooper thymectomy retractor highlight modern aspects in video-assisted thoracic surgery, which provided an excellent outcome, involving one of the lowest mediastinal thyroids to be removed by this specific procedure. Awareness of such unusual entities helps inform individualised, multidisciplinary decisions for optimum prognoses. Full article
(This article belongs to the Special Issue Recent Advances in Modern Thoracic Surgery)
Show Figures

Figure 1

Figure 1
<p>Baseline computed tomography scan. <b>Upper line</b>: Intravenous contrast-enhanced computed tomography: a tumour (yellow arrow) of 3.14 by 3.02 by 3.22 cm at the level of the lower part of the upper anterior mediastinum close to the middle mediastinum (<b>left</b>: axial plane; <b>right</b>: coronal plane). <b>Lower line</b>: <b>Left</b>: intravenous contrast thoracic computed tomography showing a hypodense nodule in the thymic area of 2.03 by 1.33 cm (axial plane); <b>Right</b>: intravenous contrast computed tomography showing an oval, well-shaped tumour on the left adrenal gland of 2.37 by 2.76 by 2.99 cm (adrenal incidentaloma—yellow arrow) located in contact with the splenic artery and vein (anterior), respectively, with upper left kidney pole (caudal); the right adrenal gland had a normal imagery aspect (axial plane).</p>
Full article ">Figure 1 Cont.
<p>Baseline computed tomography scan. <b>Upper line</b>: Intravenous contrast-enhanced computed tomography: a tumour (yellow arrow) of 3.14 by 3.02 by 3.22 cm at the level of the lower part of the upper anterior mediastinum close to the middle mediastinum (<b>left</b>: axial plane; <b>right</b>: coronal plane). <b>Lower line</b>: <b>Left</b>: intravenous contrast thoracic computed tomography showing a hypodense nodule in the thymic area of 2.03 by 1.33 cm (axial plane); <b>Right</b>: intravenous contrast computed tomography showing an oval, well-shaped tumour on the left adrenal gland of 2.37 by 2.76 by 2.99 cm (adrenal incidentaloma—yellow arrow) located in contact with the splenic artery and vein (anterior), respectively, with upper left kidney pole (caudal); the right adrenal gland had a normal imagery aspect (axial plane).</p>
Full article ">Figure 2
<p>Computed tomography scan after 1-year surveillance. <b>Upper line</b>: Non-enhanced thoracic computed tomography scan: solid nodule (yellow arrow) with heterogeneous aspect and micro- and macro-calcifications, with similar density to the thyroid parenchyma (63 HU) in the lower part of the upper anterior mediastinum (3.27 by 3.22 by 4.31 cm; the lower pole comes in close contact with subclavian arteries (bilaterally) (<b>left</b>: axial plane; <b>right</b>: coronal plane). <b>Lower line</b>: <b>Left</b>: Non-contrast enhanced computed tomography scan: a hypodense nodule (yellow arrow) of 1.55 by 1.74 cm at the level of thymus area (axial plane); <b>Right</b>: Non-enhanced abdominal computed tomography scan: oval, hypodense, well-shaped tumour mass (yellow arrow) of 2.4 by 2.7 by 3 cm (−3 HU) in the body of the left adrenal gland (adrenal incidentaloma) (axial plane).</p>
Full article ">Figure 3
<p>99m-Tc pertechnetate scintigraphy (259 MBq). (<b>A</b>) Inhomogeneous area of tracer uptake at the level of median line at the upper mediastinum without contact with the thyroid gland, suggesting an ectopic mediastinal thyroid (green arrow). (<b>B</b>) Anatomical landmarks (red arrows) in 99m-Tc scintigraphy; the ectopic thyroid was situated next to the middle mediastinum.</p>
Full article ">Figure 4
<p>Intra-operatory aspects. <b>Upper line</b>: Intra-operatory captures: (<b>left</b>) cervical incision; (<b>right</b>) Cooper thymectomy retractor retrosternal blade in place (pink arrow); cervical incision (yellow arrow). <b>Lower line</b>: Gross specimen of the removed masses: (<b>left</b>) ectopic thyroid gross specimen; (<b>right</b>) thymus gross specimen.</p>
Full article ">Figure A1
<p>Intra-operatory aspect: Cooper thymectomy retractor in place.</p>
Full article ">Figure A2
<p>(<b>A</b>) Computed tomography scan: sagittal section, showing the retrosternal mass depth related to the jugular notch (yellow dotted line) and the manubrium (blue arrow). (<b>B</b>) Computed tomography scan: coronal section showing the small vessels (yellow arrow) originating from the left brachicephalic vein (pink arrow), reaching the bottom of the mediastinal mass.</p>
Full article ">Figure A3
<p>Case report timeline and presented it according to CARE guidelines.</p>
Full article ">Figure A4
<p>Anterior neck ultrasound: (<b>left</b>) left thyroid lobe of 1.7 by 1.4 by 4.1 cm, with a hypoechoic micro-nodule of 0.4 by 0.4 by 0.5 cm and a cyst of 0.3 by 0.2 by 0.3 cm in the upper half (longitudinal plane); (<b>right</b>) right thyroid lobe of 1.8 by 1.2 by 4.3 cm, with a micro-cyst of 0.4 by 0.2 by 0.4 cm in the medium third (longitudinal plane).</p>
Full article ">Figure A5
<p>Intra-operatory aspects. (<b>Right and middle</b>): enlarged thymus gland (yellow arrow); ectopic thyroid (blue arrow)—different captures. (<b>Left</b>): Cooper thymectomy retractor retrosternal blade (pink arrow); ectopic thyroid (blue arrow).</p>
Full article ">Figure A6
<p>Post-operatory histological exam (microscopic analysis): (<b>left</b>) ectopic thyroid tissue with dystrophic calcifications (haematoxylin-eosin, magnification 4×); (<b>middle</b>) thymus mass: reactive hyperplasia (haematoxylin-eosin, magnification 4×); (<b>right</b>) thymus mass: reactive hyperplasia (haematoxylin-eosin, magnification 10×).</p>
Full article ">Figure A7
<p>Post-surgery aspects. (<b>Left</b>) Post-cervicotomy scar three months since ectopic thyroid removal; (<b>middle</b> + <b>right</b>) Computed tomography (non-enhanced phase): post-surgical aspect of the superior mediastinum after ectopic thyroid removal (normal presentation); axial plane (<b>middle</b>) and coronal plane (<b>right</b>).</p>
Full article ">
17 pages, 3804 KiB  
Case Report
Three-Leaf-Clover Thyroid and Minimally Invasive Trans-Cervical Synchronous Thyroidectomy and Ectopic Mediastinal Thyroid Tissue Removal: Does the Age of the Patient Count amid a Multifaceted Strategy?
by Claudiu Nistor, Mihai-Lucian Ciobica, Oana-Claudia Sima, Anca-Pati Cucu, Mihai Costachescu, Adrian Ciuche, Lucian-George Eftimie, Dana Terzea and Mara Carsote
Clin. Pract. 2024, 14(6), 2228-2244; https://doi.org/10.3390/clinpract14060175 - 22 Oct 2024
Viewed by 1061
Abstract
Background: Ectopic organ-associated conditions belong to the larger panel of developmental ailments, and among this challenging medical and surgical chapter, ectopic endocrine glands-related picture is mostly focused on the presence of the ectopic parathyroid and thyroid. Ectopic thyroid tissue within mediastinum (ETTM) stands [...] Read more.
Background: Ectopic organ-associated conditions belong to the larger panel of developmental ailments, and among this challenging medical and surgical chapter, ectopic endocrine glands-related picture is mostly focused on the presence of the ectopic parathyroid and thyroid. Ectopic thyroid tissue within mediastinum (ETTM) stands for a less common ETT site; while, globally, less than 1% of the mediastinum masses are ETTM. Objective: We aim to introduce a rare case of ETTM in a senior lady to whom one-time synchronous thyroidectomy with ETT removal was successfully performed via a minimally invasive modern procedure upon cervicotomy and intra-operatory use of the Cooper thymectomy retractor. Results: The panel of pros and cons with respect to providing endocrine thoracic surgery for ETTM resection in a 73-year-old subject is discussed amid a PubMed search of original English-language original reports from January 2000 until 15 August 2024 in order to identify similar distinct cases (individuals of 70 years or older who underwent surgery for ETTM). Conclusions: 1. We propose the term “three-leaf-clover thyroid” to capture the imaging essence of having an enlargement of both (eutopic) thyroid lobes and ETTM. 2. The modern surgical approach under these circumstances provided a rapid patient recovery with a low rate of complications and a minimum hospital stay. Hence, the procedure may be expanded to older patients after a careful consideration of their co-morbidities and of the need to releasing connected complaints (e.g., a 7-month history of intermittent dyspneea was found in this case with post-operatory remission). 3. The management remains a matter of individualised decision, and age may not be a limiting factor. 4. At the present time, this case adds to the very limited number of similar published cases in the mentioned age group that we could identify (seven patients, aged between 72 and 84; male-to-female ratio of 5 to 2; the rate of malignant ETTM was 3/7); of these cases, not all were reported to have a trans-cervical approach, and none reported the use of the Cooper thymectomy retractor to help the overall surgical procedure. This innovative surgical procedure offers the advantage of avoiding a sternotomy incision which has clear functional and aesthetic implications, while the video-assisted approach allows optimal visualization of the mediastinal anatomy and safe vascular sealing under visual control, without the risk of a major hemorrhage. Full article
Show Figures

Figure 1

Figure 1
<p>ETTM first suspicion (yellow arrow) amid contrast CT evaluation: a nodular, hyper-dense mass, with inhomogeneous iodophilia, of 2 cm (transverse diameter) by 2.5 cm (antero-posterior diameter) by 3.1 cm (cranio-caudal diameter), located on the median line of the upper mediastinum, posterior to the manubrium, anterior to the trachea, inferior to the thyroid gland and superior to the aortic arch (axial plane).</p>
Full article ">Figure 2
<p>ETTM aspects (yellow arrow): MRI with IV contrast showing a nodule of 2.1 by 2.6 by 3 cm in the pre-vascular compartment of the upper mediastinum on the median line (pre-tracheal): (<b>left</b>) T2 moderate hypo-intensity and (<b>right</b>) T1 iso-intensity.</p>
Full article ">Figure 3
<p>99m-Tc pertechnetate (148 MBq; effective dose 1.924 mSv) thyroid scintigraphy: an area of increased uptake in the upper part of the right thyroid lobe (orthotropic multinodular gland = green arrows) and an area of hyper-functional retrosternal thyroid tissue with hot nodules (ETTM = red arrows).</p>
Full article ">Figure 4
<p>Timeline of imaging evaluation amid ETTM identification in a 73-year-old patient.</p>
Full article ">Figure 5
<p>Anterior neck ultrasound: hypoechoic mass (ETTM) extending from the right thyroid lobe, with a structure similar to the thyroid and pre-tracheal extension of 3.66 by 2 by 2.6 cm (longitudinal plane).</p>
Full article ">Figure 6
<p>Contrast-enhanced CT scan showed: (<b>A</b>) Coronal plane (two different sections): 1—trachea; 2—right thyroid lobe; 3—left thyroid lobe; 4—ascending aorta; 5—brachiocephalic trunk; 6—left common carotid artery; ectopic thyroid (pink arrow); arterial supply (yellow arrow) for the ectopic thyroid, originating from the left common carotid artery. (<b>B</b>) Sagittal plane: 1—trachea; 2—ascending aorta; venous supply (red arrow) for ectopic thyroid, originating from the left brachiocephalic venous trunk; ectopic thyroid (pink arrow); manubrium (blue arrow).</p>
Full article ">Figure 7
<p>Intra-operatory capture: 1—cervical incision; 2—Farabeuf retractors; Cooper thymectomy retractor (pink arrow).</p>
Full article ">Figure 8
<p>Intra- aspects: gross appearance of the upper mediastinum: (<b>A</b>) ectopic thyroid tissue (pink arrow), LigaSure sealer and divider (yellow arrow), the anterior compartment of the mediastinum (green arrow); (<b>B</b>) ectopic thyroid (pink arrow), Cooper thymectomy retractor (yellow arrow), the anterior compartment of the mediastinum (green arrow), Farabeuf retractors (blue arrows).</p>
Full article ">Figure 9
<p>Pathological exam (microscopic aspects of ETTM; haematoxylin–eosin): aniso-follicular adenomatosis, hyperplastic epithelial areas with hyper-functional aspects, hemorrhage areas, siderophages, interstitial edema, and sclerosis. (<b>A</b>) 2×. (<b>B</b>) 4×.</p>
Full article ">Figure 10
<p>Post-operatory scar one month following one-time total thyroidectomy and ETTM removal via cervical Kocher incision.</p>
Full article ">Figure 11
<p>Anterior cervical ultrasonography after total thyroidectomy and ETTM removal: cervical edema and no thyroid tissue remnants.</p>
Full article ">Figure 12
<p>Three-leaf-clover thyroid as suggested by the two (enlarged) lobes of the neck thyroid and the presence of ETTM within the upper anterior mediastinum [<a href="#B24-clinpract-14-00175" class="html-bibr">24</a>].</p>
Full article ">Figure 13
<p>Tailored strategy amid ETTM removal in a senior patient according to our case: pros and cons to be taken into consideration with regard to the surgery decision [<a href="#B20-clinpract-14-00175" class="html-bibr">20</a>,<a href="#B21-clinpract-14-00175" class="html-bibr">21</a>,<a href="#B22-clinpract-14-00175" class="html-bibr">22</a>,<a href="#B23-clinpract-14-00175" class="html-bibr">23</a>,<a href="#B24-clinpract-14-00175" class="html-bibr">24</a>,<a href="#B25-clinpract-14-00175" class="html-bibr">25</a>,<a href="#B26-clinpract-14-00175" class="html-bibr">26</a>,<a href="#B27-clinpract-14-00175" class="html-bibr">27</a>,<a href="#B28-clinpract-14-00175" class="html-bibr">28</a>,<a href="#B29-clinpract-14-00175" class="html-bibr">29</a>,<a href="#B30-clinpract-14-00175" class="html-bibr">30</a>,<a href="#B31-clinpract-14-00175" class="html-bibr">31</a>,<a href="#B32-clinpract-14-00175" class="html-bibr">32</a>,<a href="#B33-clinpract-14-00175" class="html-bibr">33</a>].</p>
Full article ">
11 pages, 512 KiB  
Article
Cine-MRI and T1TSE Sequence for Mediastinal Mass
by Matthias Grott, Nabil Khan, Martin E. Eichhorn, Claus Peter Heussel, Hauke Winter and Monika Eichinger
Cancers 2024, 16(18), 3162; https://doi.org/10.3390/cancers16183162 - 15 Sep 2024
Viewed by 690
Abstract
Background/Objectives: Contrast-enhanced computed tomography (CT) is the standard radiologic examination for evaluating the extent of mediastinal tumors. If tumor infiltration into the large central thoracic vessels, the pericardium, or the myocardium is suspected, cine magnetic resonance imaging (cine-MRI) can provide additional valuable information. [...] Read more.
Background/Objectives: Contrast-enhanced computed tomography (CT) is the standard radiologic examination for evaluating the extent of mediastinal tumors. If tumor infiltration into the large central thoracic vessels, the pericardium, or the myocardium is suspected, cine magnetic resonance imaging (cine-MRI) can provide additional valuable information. Methods: We conducted a retrospective study of patients with mediastinal tumors who were staged with CT, cine-MRI, and a T1-weighted turbo spin echo (T1TSE) prior to surgical resection. Imaging was re-evaluated regarding tumor infiltration into the pericardium, myocardium, superior vena cava, aorta, pulmonary arteries, and atria and compared with intraoperative findings and postoperative histopathological reports (gold standard). Unclear CT findings were further investigated. Results: Forty-seven patients (29 female and 18 male patients; median age: 58 years) met the inclusion criteria. Cine-MRI was able to predict infiltration of the aorta in 86%, pulmonary arteries in 85%, and atria in 80% of unclear CT cases. Aortic tumor infiltration in unclear CT cases was significantly more often correctly diagnosed with cine-MRI than with T1TSE sequence. Conclusions: Additional cine-MRI is of crucial benefit in unclear CT cases. We recommend performing cine-MRI if infiltration into the large central vessels and atria is suspected. T1TSE sequence is of very limited additional value. Full article
Show Figures

Figure 1

Figure 1
<p>Patient flowchart: flowchart showing patient selection. cine-MRI = cine magnetic resonance imaging, T1TSE = magnetic resonance imaging (MRI)/T1-weighted spin echo sequences, CT = computed tomography.</p>
Full article ">
11 pages, 4245 KiB  
Article
Role of Cine-Magnetic Resonance Imaging in the Assessment of Mediastinal Masses with Uncertain/Equivocal Findings from Pre-Operative Computed Tomography Scanning
by Umberto Cariboni, Lorenzo Monti, Emanuele Voulaz, Efrem Civilini, Enrico Citterio, Costanza Lisi and Giuseppe Marulli
Diagnostics 2024, 14(15), 1682; https://doi.org/10.3390/diagnostics14151682 - 2 Aug 2024
Viewed by 911
Abstract
Background: Malignant neoplasms originating from or involving the mediastinum represent a diagnostic and therapeutic challenge when they are in contact with nearby cardiovascular structures. We aimed to test the diagnostic accuracy of cine-magnetic resonance imaging (cine-MRI) in detecting the infiltration of cardiovascular structures [...] Read more.
Background: Malignant neoplasms originating from or involving the mediastinum represent a diagnostic and therapeutic challenge when they are in contact with nearby cardiovascular structures. We aimed to test the diagnostic accuracy of cine-magnetic resonance imaging (cine-MRI) in detecting the infiltration of cardiovascular structures in cases with uncertain or equivocal findings from contrast-enhanced Computed Tomography (CT) scanning. Methods: Fifty patients affected by tumors with a suspected invasion of mediastinal cardiovascular structures at the pre-operative chest CT scan stage underwent cine-MRI before surgery at our Institution. Intraoperative findings and the histological post-surgical report were used as a reference standard to define infiltration. Inter- and intra-observer agreement for CT scans and cine-MRI were also computed over a homogenous sample of 14 patients. Results: Cine-MRI had a higher negative predictive value (93% vs. 54%, p < 0.001) than CT scans, higher sensitivity (91% vs. 16%, p < 0.001), as well as greater accuracy (66% vs. 50%, p < 0.001) in detecting cardiovascular invasion. Cine-MRI also showed better inter- and intra-observer agreement for infiltration detection. Conclusions: Cine-MRI outperforms conventional contrast-enhanced chest CT scans in the preoperative assessment of cardiovascular infiltration by mediastinal or pulmonary tumors, making it a useful imaging modality in the preoperative staging and evaluation of patients with equivocal findings at the chest CT scan stage. Full article
(This article belongs to the Special Issue Medical Radiology in Italy: Current Progress)
Show Figures

Figure 1

Figure 1
<p>(<b>a</b>) Axial contrast-enhanced CT showing a fat cleavage between the ascending aorta and the tumor and (<b>b</b>) cine-MRI showing “India Ink” artifact between the two (yellow arrows). Infiltration of the aorta was absent at surgery.</p>
Full article ">Figure 2
<p>(<b>a</b>) Axial contrast-enhanced CT showing irregular margins at the left innominate vein and superior vena cava confluence and (<b>b</b>) cine-MRI of the same patient with no “India Ink” artifact between the mass and the vessels, suspicious for infiltration (yellow arrows). Infiltration of the left brachiocephalic vein was confirmed at surgery.</p>
Full article ">Figure 3
<p>Histogram representation of CT (blue) and cine-MRI (orange) comparison of sensitivity, specificity, accuracy, positive and negative predictive values in detecting infiltration.</p>
Full article ">Figure 4
<p>The case of a 50 y.o. patient affected by a mediastinal sarcoma in which pre-operative chest CT posed the suspicion of ascending aorta infiltration by the mass: image (<b>a</b>) shows the absence of adipose tissue cleavage between the mass and the aorta (yellow arrows) in the axial plane. Cine-MRI (image (<b>b</b>)) shows the “India Ink” artifact between the vessel and the mass (yellow arrows), excluding the presence of infiltration. Intraoperative evidence and final histological report confirmed cine-MRI findings, excluding vascular infiltration.</p>
Full article ">Figure 5
<p>The case of a 49 y.o. patient affected by a thymoma in which pre-operative chest CT posed the suspicion of superior vena cava infiltration by the mass: image (<b>a</b>) shows the absence of adipose tissue cleavage between the mass and the vessel (yellow arrow) in the axial plane. Cine-MRI (image (<b>b</b>)) excluded the infiltration according to the presence of the “India Ink” artifact between thymoma and superior vena cava (yellow arrow). Image (<b>c</b>) shows an intra-operatory picture of the suspicious site of infiltration, the superior vena cava (yellow arrow), which was finally excluded by pathological report. In the adjunctive material, pure axial SSFP demonstrated reciprocal sliding motion and the “India Ink” artifact between the mass and the superior vena cava.</p>
Full article ">
11 pages, 570 KiB  
Article
B–NHL Cases in a Tertiary Pediatric Hematology—Oncology Department: A 20-Year Retrospective Cohort Study
by Ioannis Kyriakidis, Iordanis Pelagiadis, Maria Stratigaki, Nikolaos Katzilakis and Eftichia Stiakaki
Life 2024, 14(5), 633; https://doi.org/10.3390/life14050633 - 16 May 2024
Cited by 1 | Viewed by 1635
Abstract
Non-Hodgkin lymphoma (NHL) is among the five most common pediatric cancer diagnoses in children and adolescents and consists of a heterogeneous group of lymphoid tissue malignancies –with B-cell-derived NHL accounting for nearly 80% of cases. Novel and high-throughput diagnostic tools have significantly increased [...] Read more.
Non-Hodgkin lymphoma (NHL) is among the five most common pediatric cancer diagnoses in children and adolescents and consists of a heterogeneous group of lymphoid tissue malignancies –with B-cell-derived NHL accounting for nearly 80% of cases. Novel and high-throughput diagnostic tools have significantly increased our understanding of B-NHL biology and molecular pathogenesis, leading to new NHL classifications and treatment options. This retrospective cohort study investigated 17 cases of both mature B-cell NHL (Burkitt lymphoma or BL; Diffuse large B-cell lymphoma or DLBCL; Primary mediastinal large B-cell lymphoma or PMBCL; Follicular lymphoma or FL) and immature B-cell progenitor NHL (B-lymphoblastic lymphoma or BLL) that were treated in a tertiary Pediatric Hematology-Oncology Department during the last 20 years. Modern NHL protocols for children, adolescents, and young adults, along with the addition of rituximab, are safe and efficient (100% overall survival; one relapse). Elevated ESR was more prevalent than elevated LDH. Analyses have focused on immune reconstitution (grade ≥3 infections, lymphocyte and immunoglobulin levels recovery) and body-mass-index changes post-treatment, late effects (in 53% of patients), and the presence of histology markers BCL2, BCL6, CD30, cMYC, and Ki-67%. One patient was diagnosed with a second malignant neoplasm (papillary thyroid cancer). Full article
(This article belongs to the Special Issue B-cell Lymphoma)
Show Figures

Figure 1

Figure 1
<p>Swimmer plot of the B-NHL cohort.</p>
Full article ">
7 pages, 6634 KiB  
Case Report
Complex Presentation of Lung Cancer with Obstructive Jaundice
by Ruxandra Oprita, Bogdan Oprita, Ioana Adriana Serban, Lidia Aurelia Stefan, Ciprian Mihai Neacsu, Alice Elena Diaconu and Valentin Enache
Reports 2024, 7(2), 30; https://doi.org/10.3390/reports7020030 - 24 Apr 2024
Viewed by 1907
Abstract
Background: Lung cancer, particularly small-cell lung carcinoma (SCLC), often presents with respiratory symptoms. However, atypical manifestations including jaundice and abdominal pain can obscure the diagnosis, leading to challenges in early detection and treatment. Case Presentation: A 49-year-old male, with a history of smoking [...] Read more.
Background: Lung cancer, particularly small-cell lung carcinoma (SCLC), often presents with respiratory symptoms. However, atypical manifestations including jaundice and abdominal pain can obscure the diagnosis, leading to challenges in early detection and treatment. Case Presentation: A 49-year-old male, with a history of smoking and diagnosed with Chronic Obstructive Pulmonary Disease (COPD), presented to the emergency department with a 3-day history of jaundice and a 3-week duration of mild abdominal pain. Initial investigations, including blood tests, showed hyperbilirubinemia and elevated lipase and amylase levels. An abdominal ultrasound was performed and revealed a hypoechoic, inhomogeneous mass in the head of the pancreas and multiple liver masses, suggesting a cephalo-pancreatic formation with liver metastasis. Further diagnostic procedures, including upper endoscopy and ERCP, followed by a TAP CT scan, identified a large mediastinal-pulmonary mass with invasion into major vessels and extensive metastasis. The immunohistochemical analysis of a duodenal ulcer biopsy confirmed a diagnosis of duodenal metastasis from a small-cell neuroendocrine lung carcinoma. Conclusion: Our case highlights that while rare, the possibility of metastatic spread should be included in the differential diagnosis when obstructive jaundice occurs in the context of high-risk factors for lung cancer. Full article
Show Figures

Figure 1

Figure 1
<p>Duodenal ulcer distal to the papillary apparatus—endoscopic view.</p>
Full article ">Figure 2
<p>Right mediastinal pulmonary tumor process with vascular and cardiac invasion, associated with ipsilateral pleural effusion, with a most likely malignant substrate.</p>
Full article ">Figure 3
<p>Diffuse tumor infiltrating the pancreas, associated with numerous adjacent peritoneal and retroperitoneal metastases. Renal metastases.</p>
Full article ">Figure 4
<p>H&amp;E stain 400×—Duodenal mucosa with monomorphic cells with hyperchromatic nuclei.</p>
Full article ">Figure 5
<p>Ki67 positive 60% 100×—Sixty percent of the examined cancer cells are actively proliferating.</p>
Full article ">Figure 6
<p>Synaptophysin (a protein found in the membranes of synaptic vesicles) positive 200×.</p>
Full article ">
8 pages, 3489 KiB  
Case Report
Daratumumab and Nelarabine Treatment as Salvage Therapy for T-Lymphoblastic Lymphoma: A Case Report
by Gonzalo Castellanos, Laura Pardo, Alberto López, Javier Cornago, Jose Luis López, Alicia de las Heras, Francisco J. Díaz, Marta Martínez de Bourio, Eva Castillo, Pilar Llamas and Laura Solán
Biomedicines 2024, 12(3), 512; https://doi.org/10.3390/biomedicines12030512 - 24 Feb 2024
Viewed by 1453
Abstract
T-cell lymphoblastic lymphoma is an uncommon lymphoid neoplasm in adults, although more frequent in children and teenagers, that often affects the mediastinum and bone marrow, requiring intensive chemotherapy protocols. Its prognosis is poor if a cure is not achieved with first-line treatments. We [...] Read more.
T-cell lymphoblastic lymphoma is an uncommon lymphoid neoplasm in adults, although more frequent in children and teenagers, that often affects the mediastinum and bone marrow, requiring intensive chemotherapy protocols. Its prognosis is poor if a cure is not achieved with first-line treatments. We present a case report of a 19-year-old man diagnosed with this type of lymphoma due to significant respiratory distress and a mediastinal mass. He received treatment according to the hyper-CVAD regimen, with a complete metabolic response. However, seven months later a new mediastinal growth was observed, leading to salvage treatment with a combination of nelarabine and daratumumab. We observed not only refractoriness, but also leukemization, which prompted consideration of hematopoietic stem cell transplantation. Based on this case, we conducted a review of pharmacological treatment options for refractory or relapsed lymphoblastic lymphoma, as well as the role of radiotherapy in managing mediastinal disease. This case report highlights the limited evidence available regarding later-line treatments, with unusual reports regarding employing our combination of daratumumab and nelarabine, and emphasizes the importance of achieving cures in the first line of treatment. Full article
(This article belongs to the Section Cancer Biology and Oncology)
Show Figures

Figure 1

Figure 1
<p>Radiological findings in our case evolution. (<b>A</b>) (<b>A.1</b>) Maximum intensity projection (MIP) image of positron emission tomography (PET) using 18F-Fluorodeoxyglucose (18F-FDG) as radiotracer. Hypercaptant mediastinal mass (arrow) with heterogeneous distribution suggestive of thymoma/lymphoproliferative syndrome at the time of diagnosis; (<b>A.2</b>) fusion images, sagittal axe. (<b>B</b>) (<b>B.1</b>) MIP image of PET using 18F-FDG as tracer. Supradiaphragmatic and cervical adenopathy clusters with a bulky mediastinal mass (arrow) and pathological FDG bone deposits in both femurs during the first relapse; (<b>B.2</b>) fusion images, sagittal axe. (<b>C</b>) Remarkable reduction in the size of the mediastinal mass, although newly observed hepatomegaly (arrow) after salvage therapy.</p>
Full article ">Figure 2
<p>Relapse mediastinal mass biopsy, 10× photography. Immunohistochemical analysis revealed a distinctly positive expression for CD38 (transmembrane glycoprotein and a marker of lymphocyte differentiation and activation) in tumoral cells’ surfaces in the excisional biopsy of the mediastinal mass, conducted subsequent to radiological confirmation of relapse.</p>
Full article ">Figure 3
<p>Treatment sequence. Timeline illustrating the progression of disease from diagnosis to the patient’s end. As described above, the initial approach involved the administration of the hyper-CVAD regimen as our first-line treatment, which resulted in a complete radiological response. Upon confirming the relapse, nelarabine was administered, followed by the addition of daratumumab and mediastinal radiotherapy. Following the second progression, a prephase was initiated, and HSCT was considered; ultimately the patient opted for palliative care.</p>
Full article ">
8 pages, 5981 KiB  
Case Report
Resection of a Large Growing Mediastinal Germ Cell Tumor Using a Multidisciplinary Approach
by Alison Greene, Lori Wood, Philip Champion, Mathieu Castonguay, Matthias Scheffler, Catherine Deshaies, Jeremy Wood and Daniel French
Curr. Oncol. 2024, 31(1), 42-49; https://doi.org/10.3390/curroncol31010003 - 21 Dec 2023
Viewed by 1451
Abstract
Mediastinal germ cell tumors (GCTs) are rare. Post-chemotherapy residual masses in patients with a nonseminomatous GCT require resection. A patient with a large mediastinal GCT involving the left subclavian artery, superior vena cava (SVC) and hilum of the right lung is presented. Despite [...] Read more.
Mediastinal germ cell tumors (GCTs) are rare. Post-chemotherapy residual masses in patients with a nonseminomatous GCT require resection. A patient with a large mediastinal GCT involving the left subclavian artery, superior vena cava (SVC) and hilum of the right lung is presented. Despite a biochemical response to chemotherapy, the tumor enlarged on serial imaging. With guidance from medical oncology, a multidisciplinary surgical team, including cardiac anesthesia, cardiac surgery and thoracic surgery resected the tumor with a staged reconstruction of the SVC. The procedure was well tolerated and yielded clear margins. The final pathology showed a significant associated component of rhabdomyosarcoma. Full article
(This article belongs to the Section Thoracic Oncology)
Show Figures

Figure 1

Figure 1
<p>Computed tomography (CT) scan image of mediastinal mass at the time of initial presentation.</p>
Full article ">Figure 2
<p>Computed tomography (CT) scan image of mediastinal mass after two cycles of chemotherapy showing interval growth of tumor despite a biochemical response.</p>
Full article ">Figure 3
<p>Computed tomography (CT) scan image of mediastinal mass after two cycles of chemotherapy showing encasement of left subclavian artery.</p>
Full article ">Figure 4
<p>A photograph of the resected specimen.</p>
Full article ">Figure 5
<p>(<b>A</b>), Cross-section photograph of resected tumor specimen; (<b>B</b>) low-power photomicrograph, with mature teratoma (right side of image) and yolk sac tumor (*) components, accompanied by fibrosis (H&amp;E, original magnification ×20); (<b>C</b>) rhabdomyosarcoma (*) admixed with mature teratoma (right side of image) (H&amp;E, original magnification ×100); (<b>D</b>) rhabdomyosarcoma cells (H&amp;E, original magnification ×200) (inset, desman immunohistochemical study).</p>
Full article ">
15 pages, 3531 KiB  
Article
Patient Dose Estimation in Computed Tomography-Guided Biopsy Procedures
by Evangelia Siomou, Dimitrios K. Filippiadis, Efstathios P. Efstathopoulos, Ioannis Antonakos and George S. Panayiotakis
J. Imaging 2023, 9(12), 267; https://doi.org/10.3390/jimaging9120267 - 30 Nov 2023
Viewed by 3419
Abstract
This study establishes typical Diagnostic Reference Levels (DRL) values and assesses patient doses in computed tomography (CT)-guided biopsy procedures. The Effective Dose (ED), Entrance Skin Dose (ESD), and Size-Specific Dose Estimate (SSDE) were calculated using the relevant literature-derived conversion factors. A retrospective analysis [...] Read more.
This study establishes typical Diagnostic Reference Levels (DRL) values and assesses patient doses in computed tomography (CT)-guided biopsy procedures. The Effective Dose (ED), Entrance Skin Dose (ESD), and Size-Specific Dose Estimate (SSDE) were calculated using the relevant literature-derived conversion factors. A retrospective analysis of 226 CT-guided biopsies across five categories (Iliac bone, liver, lung, mediastinum, and para-aortic lymph nodes) was conducted. Typical DRL values were computed as median distributions, following guidelines from the International Commission on Radiological Protection (ICRP) Publication 135. DRLs for helical mode CT acquisitions were set at 9.7 mGy for Iliac bone, 8.9 mGy for liver, 8.8 mGy for lung, 7.9 mGy for mediastinal mass, and 9 mGy for para-aortic lymph nodes biopsies. In contrast, DRLs for biopsy acquisitions were 7.3 mGy, 7.7 mGy, 5.6 mGy, 5.6 mGy, and 7.4 mGy, respectively. Median SSDE values varied from 7.6 mGy to 10 mGy for biopsy acquisitions and from 11.3 mGy to 12.6 mGy for helical scans. Median ED values ranged from 1.6 mSv to 5.7 mSv for biopsy scans and from 3.9 mSv to 9.3 mSv for helical scans. The study highlights the significance of using DRLs for optimizing CT-guided biopsy procedures, revealing notable variations in radiation exposure between helical scans covering entire anatomical regions and localized biopsy acquisitions. Full article
(This article belongs to the Section Medical Imaging)
Show Figures

Figure 1

Figure 1
<p>Box plots of the distribution of CTDI<sub>vol</sub> values for CT-guided procedures at helical acquisitions.</p>
Full article ">Figure 2
<p>Box plots of the distribution of CTDI<sub>vol</sub> values for CT-guided procedures at biopsy acquisitions.</p>
Full article ">Figure 3
<p>Box plots of the distribution of DLP values for CT-guided procedures at helical acquisitions.</p>
Full article ">Figure 4
<p>Box plots of the distribution of DLP values for CT-guided procedures at biopsy acquisitions.</p>
Full article ">Figure 5
<p>Distribution of (<b>a</b>) ESD (mGy) and (<b>b</b>) ED (mSv) at helical and biopsy mode of CT-guided Iliac bone biopsy procedure.</p>
Full article ">Figure 6
<p>Distribution of (<b>a</b>) ESD (mGy) and (<b>b</b>) ED (mSv) at helical and biopsy mode of CT-guided liver biopsy procedure.</p>
Full article ">Figure 7
<p>Distributions of (<b>a</b>) ESD (mGy) and (<b>b</b>) ED (mSv) at helical and biopsy mode of CT-guided lung biopsy procedure.</p>
Full article ">Figure 8
<p>Distribution of (<b>a</b>) ESD (mGy) and (<b>b</b>) ED (mSv) at helical and biopsy mode of CT-guided mediastinum biopsy procedure.</p>
Full article ">Figure 9
<p>Distribution of (<b>a</b>) ESD (mGy) and (<b>b</b>) ED (mSv) at helical and biopsy mode of CT-guided para-aortic lymph nodes biopsy procedure.</p>
Full article ">Figure 10
<p>Typical DRL values in terms of CTDI<sub>vol</sub> (mGy) at helical and biopsy scans for CT-guided biopsies.</p>
Full article ">
18 pages, 14434 KiB  
Review
Approach to Imaging of Mediastinal Masses
by Jitesh Ahuja, Chad D. Strange, Rishi Agrawal, Lauren T. Erasmus and Mylene T. Truong
Diagnostics 2023, 13(20), 3171; https://doi.org/10.3390/diagnostics13203171 - 11 Oct 2023
Cited by 6 | Viewed by 7976
Abstract
Mediastinal masses present a diagnostic challenge due to their diverse etiologies. Accurate localization and internal characteristics of the mass are the two most important factors to narrow the differential diagnosis or provide a specific diagnosis. The International Thymic Malignancy Interest Group (ITMIG) classification [...] Read more.
Mediastinal masses present a diagnostic challenge due to their diverse etiologies. Accurate localization and internal characteristics of the mass are the two most important factors to narrow the differential diagnosis or provide a specific diagnosis. The International Thymic Malignancy Interest Group (ITMIG) classification is the standard classification system used to localize mediastinal masses. Computed tomography (CT) and magnetic resonance imaging (MRI) are the two most commonly used imaging modalities for characterization of the mediastinal masses. Full article
(This article belongs to the Special Issue Selected Topics in Thoracic Pathology)
Show Figures

Figure 1

Figure 1
<p>ITMIG definition of mediastinal compartments. Sagittal reformatted CT with color overlay shows mediastinal compartment borders: prevascular compartment (orange), visceral compartment (green) and paravertebral compartment (purple).</p>
Full article ">Figure 2
<p>Hilum overlay sign. Chest radiograph posteroanterior view (<b>A</b>) shows well-marginated mass over right hilum (arrowheads). Hilar vessels (arrow) are seen through the mass, suggesting the mass is either anterior or posterior to the hilum. Chest radiograph lateral view (<b>B</b>) confirms the anterior location of the mass (arrowheads).</p>
Full article ">Figure 3
<p>Thymic cyst. CT shows a fluid attenuating structure (15 Hounsfield units) in the prevascular mediastinum in the region of thymic bed (arrow).</p>
Full article ">Figure 4
<p>Pericardial cyst. CT shows a fluid attenuating structure (10 Hounsfield units) in the prevascular mediastinum at the right anterior cardiophrenic angle (arrow).</p>
Full article ">Figure 5
<p>Thymic cyst. (<b>A</b>) CT shows a well-defined homogeneous structure with density slightly higher than simple fluid (40 Hounsfield units) in the prevascular mediastinum (arrow). MRI (<b>B</b>,<b>C</b>) shows T2 hyperintensity (arrow in (<b>B</b>)) and no enhancement with gadolinium (arrow in (<b>C</b>)) consistent with fluid.</p>
Full article ">Figure 6
<p>Cystic thymoma. CT (<b>A</b>) shows a mixed attenuation (cystic and solid) mass in the prevascular mediastinum. T2W MRI (<b>B</b>) shows hyperintense cystic component and hypointense solid nodule (arrow in (<b>B</b>)). Post-gadolinium MRI (<b>C</b>) shows enhancement of the solid nodule. Pathology showed cystic thymoma.</p>
Full article ">Figure 7
<p>Thymic hyperplasia. CT (<b>A</b>) shows diffuse enlargement of the thymus maintaining its triangular or bilobed shape (arrow). Follow-up CT (<b>B</b>) 12 months later shows fatty involution of the thymus (arrow).</p>
Full article ">Figure 8
<p>Thymic hyperplasia. CT (<b>A</b>) shows a rounded soft tissue mass in the prevascular mediastinum (arrow) in a woman with breast cancer. Differential diagnosis includes thymic epithelial neoplasm or metastatic disease. MRI chest in-phase image (<b>B</b>) shows the mass is isointense to muscle (arrow) and shows drop in signal on opposed-phase image (<b>C</b>) consistent with thymic hyperplasia.</p>
Full article ">Figure 9
<p>Thymoma. CT shows a well-defined homogeneous soft tissue mass in the prevascular mediastinum (arrow).</p>
Full article ">Figure 10
<p>Thymoma with pleural drop metastasis. CT (<b>A</b>,<b>B</b>) shows a lobulated soft tissue mass in the prevascular mediastinum (arrow in (<b>A</b>)) and a diaphragmatic pleural nodule in the right lower chest (arrow in (<b>B</b>)).</p>
Full article ">Figure 11
<p>Thymic carcinoma. CT with soft tissue (<b>A</b>) and lung (<b>B</b>) window show large heterogeneous soft tissue mass in the prevascular mediastinum. Left prevascular lymphadenopathy (arrow in (<b>A</b>)) and well-marginated lung nodules (arrows in (<b>B</b>)) are compatible with metastatic disease.</p>
Full article ">Figure 12
<p>Primary mediastinal lymphoma. CT (<b>A</b>) shows large heterogeneous soft tissue mass in the prevascular mediastinum. The mass is hypermetabolic on FDG PET-CT (<b>B</b>). Biopsy showed diffuse large B cell lymphoma.</p>
Full article ">Figure 13
<p>Mature teratoma. CT axial (<b>A</b>) and coronal reformat (<b>B</b>) show a well-defined mass containing soft tissue, fat (arrow in (<b>A</b>)) and calcification (arrow in (<b>B</b>)) in the prevascular mediastinum compatible with mature teratoma.</p>
Full article ">Figure 14
<p>Nonseminomatous germ cell tumor (NSGCT). CT shows a large heterogeneous mass in the prevascular mediastinum. Biopsy showed teratoma with malignant transformation.</p>
Full article ">Figure 15
<p>Foregut duplication cyst. CT (<b>A</b>) shows a well-marginated structure in the visceral mediastinum with attenuation values slightly higher than simple fluid. MRI (<b>B</b>,<b>C</b>) show high signal intensity upon T2W imaging (arrow in (<b>B</b>)) and no enhancement upon post-gadolinium imaging (arrow in (<b>C</b>)) consistent with fluid.</p>
Full article ">Figure 16
<p>Paraganglioma. CT (<b>A</b>) shows a hypervascular mass with central necrosis in the visceral mediastinum behind the left atrium. MRI (<b>B</b>,<b>C</b>) shows the mass is hyperintense compared to muscle upon black blood double inversion MRI (arrow in (<b>B</b>)) and hypervascular upon post-gadolinium imaging (arrow in (<b>C</b>)).</p>
Full article ">Figure 17
<p>Castleman disease. CT shows hypervascular mass with a focus of calcification (arrow) in the visceral mediastinum. Biopsy showed Castleman disease.</p>
Full article ">Figure 18
<p>Esophageal carcinoma. CT shows a soft tissue mass in the visceral mediastinum inseparable from the esophagus (arrow). Biopsy showed esophageal carcinoma.</p>
Full article ">Figure 19
<p>Esophageal gastrointestinal stromal tumor (GIST). CT shows a large heterogeneous mass in the visceral mediastinum inseparable from the esophagus (arrow). Biopsy showed gastrointestinal stromal tumor.</p>
Full article ">Figure 20
<p>Schwannoma. CT (<b>A</b>) shows a well-defined spherical shaped mass in the left paraspinal region (arrow). MRI (<b>B</b>,<b>C</b>) shows the mass is hyperintense upon T2W imaging (arrow in (<b>B</b>)) and enhances with gadolinium (arrow in (<b>C</b>)).</p>
Full article ">Figure 21
<p>Extramedullary hematopoiesis. CT shows bilateral paraspinal soft tissue thickening (arrows) in a patient with leukemia and anemia.</p>
Full article ">
Back to TopTop